Seventy years of scientific advancements led to a 10,000-fold improvement in protein detection sensitivity and the possibility of early disease diagnosis.
Following innovations in amplification and scaling over the past 30 years, single cell sequencing technologies have permeated all corners of biomedical research, providing cellular insights into diseases such as heart failure or the immune response during COVID-19 infection.